ACRUX (ACR) - ASX ANNOUNCEMENT 13 JANUARY 2012
LILLY COMMENTS ON AXIRON AT JP MORGAN HEALTHCARE CONFERENCE
Acrux (ASX: ACR) today reported that John Lechleiter, Chairman, President and CEO of Eli Lilly & Company included comments on Axiron in a presentation at the JP Morgan Healthcare Conference in San Francisco. During the presentation, Dr Lechleiter commented "We've been pleased with the uptake of Axiron since it was launched last spring. The most recent IMS data show we've achieved 10% share of market in total prescriptions and that over one in five new patient starts are going to Axiron."
ContactRichard Treagus, CEO: 0417 520 509
About Acrux www.acrux.com.au